PRELIMINARY
PROGRAM

Invited Speakers Preliminary Program

**Click on the drop down of topic to view discussions

Cardio Obstetrics

Cardio-Obstetrics: Lessons that I have Learn over 3 Decades

 

Evolving Strategies for Improving the Consistency of Care in Cardiac Patient during Pregnancy

 

Getting your Cardio Obstetrics Papers Published: Perspectives from an Editor

 

Training in Cardio-Obstetrics: Challenges and Opportunities for Subspecialty Training

 

Cardiovascular Care for Pregnant Women with Cardiovascular Disease – 306 Patients the Columbia University New York Experience

 

4th Trimester- What is the Care Model for Optimizing Postpartum Cardiovascular Heath Outcome

 

Optimizing the Inclusion of Pregnant Individuals in Prospective Cohort Studies and Clinical Trials to Advance the Field of Cardio-Obstetrics

 

Developing a National Protocol for Managing Heart Disease—NPAC (National Pregnancy and Cardiac Disease) India Study Methodology

 

Artificial Intelligence-Powered Tools for Cardiac Screening in Obstetric Patients

 

Use of Genetic Testing in the Pregnant Patients with Cardiac Disease

 

Stories from the Joint Gyneco-Cardio Clinic – Does it Improve Outcomes?

 

Risk Prediction and Mortality

Universal CVD Risk Assessment in Pregnancy: Pros and Cons

 

Risk Prediction: 2025 Update

 

How to Tackle Cardiovascular Disease Related Maternal Morbidity and Mortality?

 

Adverse Pregnancy Outcomes and Long-term Risk of Cardiovascular Disease

 

What Cardiac Diagnoses are the Highest Risk? Is Pregnancy Termination Indicated?

 

Cardiac Evaluation and Imaging

Exercise and Stress Testing during Pregnancy

 

When Echocardiography should be Used in Pregnancy?

 

Cardiovascular Adaptation in Normal Pregnancy

 

Cardiac POCUS on Labor and Delivery

 

Lung POCUS on Labor and Delivery

 

Valvular Heart Disease and Pregnancy

Mechanical Valve and Pregnancy – the ROPAC Experience

 

Updating the Risk Stratification Systems in Valvular Heart Disease: The Way Forward

 

Prosthetic Heart Valve Thrombosis and the Challenges in Bridging Anticoagulation

 

Managing Stenotic Lesions in Pregnancy – Antenatal Valve Interventions, When and how?

 

Heparin in Pregnancy: Trimester Effects and Dosing Design to Meet Guidelines

 

Factors Affecting Anticoagulant Choices for Pregnant Patients with Mechanical Heart Valves Across High and Low-Resource Settings: An International Qualitative Research Study

 

The Optimal Monitoring Regimen for LMWH in Pregnant Persons with MHVs.    

 

TAVR in Pregnancy: Advantages and Limitations

 

Congenital Heart Disease and Pregnancy

Management of the Patient with Fontan Circulation during Pregnancy

 

Ebstein’s Anomaly and Pregnancy Management

 

Bicuspid Aortic Valve and Pregnancy

 

Systemic Right Ventricles and Considerations in Pregnancy

 

Pregnancy in Post Tetralogy of Fallot Repair

 

Eisenmenger Syndrome and Pregnancy

 

Maternal and Fetal Outcome of Pregnancy in Women with D-Transposition and Congenitally Corrected Transposition of the Great Vessels

 

Simplifying Congenital Heart Disease during Pregnancy 

 

Infertility and Contraceptives in Women with Cardiac Disease, IVF

Fertility Therapy Considerations in Women with Cardiac Disease

 

Infertility Success in Women over 40 Years of Age

 

Contraception for the Cardiac Patient

 

Understanding the 2024 US Medical Eligibility Criteria for Contraceptive Use

 

Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology

 

Arrhythmias and Pregnancy

Genetic Arrhythmias in Pregnancy (LQT, ARVC, etc)

 

Dysautonomia in Pregnancy

 

Advancing our Understanding of Pregnancy-Associated Atrial Fibrillation

 

Contemporary Approach to Ablation during Pregnancy

 

Management of Electrophysiological Devices in Pregnancy

 

Maternal and Fetal Implications of Transplacental Therapy for Fetal Tachycardia  

 

Peripartum Cardiomyopathy

Living with PPCM: The Patient Perspective

 

Mental Health in PPCM

 

The REBIRTH Study – Status Report

 

The EORP Dataset on Bromocriptine Use

 

Long Term Follow-Up Outcomes in Patients with PPCM

 

PPCM: Socioeconomic Factors Versus Ethnicity

 

Long-term Considerations for Patients with Peripartum Cardiomyopathy (ICD Use, Long-term Adverse Outcomes)

 

Long-term Outcome of Women with Peripartum Cardiomyopathy having Subsequent Pregnancy

 

PPCM and Subsequent Pregnancy: Results of the EHC EORP Registry

 

Geographical Differences in PPCM Presentation over the Globe

 

Cardiomyopathy, Myocarditis Heart Failure and Pericardial Disease

VV-ECMO and Pregnancy: What’s New?

 

Heart Failure with Preserved Ejection Fraction in Pregnancy

 

Management of Pregnancy after Cardiac Transplantation

 

Peripartum Takotsubo Cardiomyopathy – The Obstetrician’s Perspective

 

Pericarditis in Pregnancy – Obstetric Challenges in the Management of Recurrent Pericarditis in Pregnancy

 

Pregnancy with Severe Hypertrophic Cardiomyopathy – Experience of a Tertiary Center

 

The Risk of Pregnancy in Women with HFrEF

 

Vascular Disease in Pregnancy

Non-Marfan Aortopathy –Management in Pregnancy

 

Turner Syndrome and Pregnancy

 

The Approach to Pregnancy in Women with Marfan Aortopathy

 

Cardiac Surgery in Patients with Pregnancy Associated Aortic Dissection

 

Delivery for Women with Aortopathy and Pregnancy

 

Management during Labor and Delivery

Neuraxial Analgesia for Labor and Delivery in the Patient with Cardiovascular Disease

 

 

Maternal Cardiovascular Monitoring during Labor, Cesarean and the Postpartum

 

 

Normal Hemodynamics of Pregnancy and Delivery

 

 

What Cardiac Diagnoses are the Highest Risk? Is Pregnancy Termination Indicated?

 

 

The Use of Uterotonics in Labor and Delivery – Safety Considerations in the Cardiac Patients

 

 

Labor and Delivery Pharmacology: OB Drugs with CV Implications and CV Drugs with OB Implications

 

 

The Heart of Obstetric Care: Enhancing Antepartum and Labor Management in Cardio-Obstetrics

 

 

Heart Failure Crisis on Labor and Delivery and Hemodynamic Implications of Labor Analgesia

 

 

Critical Care Management of the Pregnant Woman with Cardiac Disease

 

 

Hypertension and Preeclampsia

Antepartum and Postpartum Management of Hypertension

 

 

Hypertensive Disease of Pregnancy: Individualization of Pharmacotherapy

 

 

Addressing Pre-Eclampsia Prevention

 

 

Cardiovascular Disease after Preeclampsia: Advances in Mechanism of Action and Clinical Interventions

 

 

Coronary Artery Disease

Pregnancy Post SCAD: Yes or No

 

Myocardial Bridge in Pregnancy- Case Series and Review

 

Coronary Interventions in Pregnancy: A Word of Caution.

 

Pregnancy with Medical Problems

Cardiometabolic Health in Pregnancy

 

Lipid in Pregnancy Update

 

Gestational Diabetes and Cardiovascular Disease

 

Risks for Pregnancy at Advanced Maternal Age- Cardiometabolic Risks

 

Addressing Psychological and Cardiovascular Health Across the Perinatal Period

 

Association of Pre-pregnancy Cardiometabolic Factors with Adverse Pregnancy Outcomes

 

Pulmonary HTN and VTE in Pregnancy

Pulmonary Arterial Hypertension in Pregnancy – What have we Learned Over the Past 2 Decades?

 

Navigating Safe Births: Pregnancy with Pulmonary Hypertension

 

How to Improve the Outcome of Pregnancy in Women with Pulmonary Arterial Hypertension

 

Registries

A Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): an International, Multi-Methods Consensus Study

 

The HOPE Pilot Results (1 Years NACE, MACE, APOs)

 

The HOPE Registry – Methods and Protocol

 

ROPAC Analysis of Obstetric Outcomes

 

Cardio-obstetric Team Approach- Ensuring Feasibility to Improve Outcome in Developing Nations- Lessons from Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR is not yet Published. Presented as Late Breaking Science at ESC 2024)

 

Pregnancy and Labor in Women with Heart Diseases. 30 years’ Experience of 800 Pregnancy. The Israel northern registry

 

An Update on the Canadian Network of Networks for Reducing Cardiovascular Mortality and Morbidity in Pregnancy (CaNCaM-Preg)

 

Biomarkers

Use of Cardiac Biomarkers in Pregnancy

 

Drugs in Pregnancy

Beta Blocker Use Considerations among Pregnant Women with Cardiac Disease

 

Betablocker use during Pregnancy – The ROPAC Experience

Pregnancy Outcomes after Cardiotoxic Cancer Therapy

 

Which Cardiovascular Medications Should Not be used during Pregnancy and Lactation and why?

 

Resuscitation in Pregnancy

Maternal Cardiac Arrest and ECPR

 

Maternal Cardiac Arrest on Labor and Delivery